Loss of heterozygosity at loci on chromosome 4, a common genetic event during the spontaneous immortalization of mouse embryonic fibroblasts

Molecular Carcinogenesis

Volumn 19, Issue 1, 1997, Pages 17-24

  Obata, Masahiko ^a   Lee, Gang Hong ^a   Kanda, Hiroaki ^b   Kitagawa, Tomoyuki ^b   Ogawa, Katsuhiro ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b CANCER INSTITUTE   (Japan)

Author keywords

Chromosome 4; Fibroblast; Immortalization; Mouse

Indexed keywords

ANIMAL CELL; ARTICLE; CELL IMMORTALIZATION; CHROMOSOME 4; CONTROLLED STUDY; EMBRYO CELL; FIBROBLAST; HETEROZYGOSITY LOSS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BLOTTING, SOUTHERN; CARRIER PROTEINS; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME ABERRATIONS; CHROMOSOMES; CYCLIN-DEPENDENT KINASE INHIBITOR P16; EMBRYO; FEMALE; FIBROBLASTS; GENE DELETION; GENES, TUMOR SUPPRESSOR; GENOME; HETEROZYGOTE; HOMOZYGOTE; MALE; MICE; MICE, INBRED STRAINS;

EID: 0030955834     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199705)19:1<17::AID-MC3>3.0.CO;2-K     Document Type: Article

References (48)

1. Todaro GJ, Green H. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J Cell Biol 17:299-313, 1963.
2. Hayflick L. Current theories of biological aging. Fed Proc 34:9-13, 1975.
3. 60Co gamma rays. Int J Cancer 35:275-280, 1985.
4. Smith JR, Ning Y, Pereira-Smith OM. Why are transformed cells immortal? Is the process reversible? Am J Clin Nutr 55:1215S-1221S, 1992.
5. Pereira-Smith OM, Smith JR. Expression of SV40 T antigen in finite life-span hybrids of normal and SV40-transformed fibroblasts. Somat Cell Genet 7:411-421, 1981.
6. Pereira-Smith OM, Smith JR. Evidence for the recessive nature of cellular immortality. Science 221:964-966, 1983.
7. Pereira-Smith OM, Smith JR. Genetic analysis of indefinite division in human cells: Identification of four complementation groups. Proc Natl Acad Sci USA 85:6042-6046, 1988.
8. Petit CA, Gardes M, Feunteun J. Immortalization of rodent embryo fibroblasts by SV40 is maintained by the A gene. Virology 127:74-82, 1983.
9. Jat PS, Sharp PA. Large T antigens of simian virus 40 and polyomavirus efficiently establish primary fibroblasts. J Virol 59:746-750, 1986.
10. Tsukada T, Tomooka Y, Takai S, et al. Enhanced proliferative potential in culture of cells from p53-deficient mice. Oncogene 8:3313-3322, 1993.
11. Harvey DM, Levine AJ. p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts. Genes Dev 5:2375-2385, 1991.
12. Rittling SR, Denhardt DT. p53 mutations in spontaneously immortalized 3T12 but not 3T3 mouse embryo cells. Oncogene 7:935-942, 1992.
13. Tokumitsu M, Kadohama T, Ogawa K. Infrequent loss of heterozygosity and mutation of the p53 gene in immortal and transformed mouse embryo fibroblasts. Mol Carcinog 10:52-57, 1994.
14. Dietrich W, Katz H, Lincoln SE, et al. A genetic map of the mouse suitable for typing intraspecific crosses. Genetics 131:423-447, 1992.
15. Love JM, Knight AM, McAleer MA, Todd JA. Towards construction of a high resolution map of the mouse genome using PCR-analysed microsatellites. Nucleic Acids Res 18:4123-4130, 1990.
16. Kanda H, Tanaka N, Miyasaka K, et al. Highly frequent MTS-1/ p16 gene deletion in DEN-induced mouse hepatoma cell lines. Proceedings of the Japanese Cancer Association 54:62, 1995.
17. Nishimori H, Ogawa K, Tateno H. Frequent deletion in chromosome 4 and duplication of chromosome 15 in liver epithelial cells derived from long-term culture of C3H mouse hepatocytes. Int J Cancer 59:108-113, 1994.
18. 1 mice exhibit parentally-biased loss of heterozygosity at the Lci (liver cell immortalization) locus on chromosome 4. Oncogene 11:2281-2287, 1995.
19. Lee G-H, Kawaguchi T, Nomura K, Kitagawa T. Establishment and characterization of a diethylnitrosamine-initiated woodchuck hepatocyte cell line. Hepatology 7:937-940, 1987.
20. Saito Y, Ogawa K. Wild type p53 and c-myc cooperation in generating apoptosis of a rat hepatocellular carcinoma cell line (FAA-HTC1). Oncogene 11:1013-1018, 1995.
21. Feinberg AP, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Addendum. Anal Biochem 137:266-267, 1984.
22. Feinberg AP, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6-13, 1983.
23. Ceci JD, Siracusa LD, Jenkins NA, Copeland NG. A molecular genetic linkage map of mouse chromosome 4 including the localization of several proto-oncogenes. Genomics 5:699-709, 1989.
24. Nobori T, Miura K, Wu D, Lois A, Takabayashi K, Carson D. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 68:753-756, 1994.
25. Kamb A, Gruis N, Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436-440, 1994.
26. INK4 deletions with monosomy 5 in kidney epithelial cell lines but not primary renal tumors. Cancer Res 55:1607-1612, 1995.
27. Funaki K, Everitt J, Oshimura M, Freed JJ, Knudson AG, Walker C. Hereditary renal cell carcinoma in the rat associated with non-random loss of chromosomes 5 and 6. Cancer Res 51:4415-4422, 1991.
28. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366:704-707, 1993.
29. INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev 8:2939-2952, 1994.
30. INK4. Science 267:249-252, 1995.
31. Spruck CH, Gonzalez-Zulueta M, Shibata A, et al. p16 gene in uncultured tumors. Nature 370:183-184, 1994.
32. Brenner AJ, Aldaz CM. Chromosome 9p allelic loss and p16/ CDKN2 deletion in breast cancer and evidence of p16 inactivation in immortal breast epithelial cells. Cancer Res 55:2892-2895, 1995.
33. Packenham JP, Taylor JA, Anna CH, White CM, Devereux TR. Homozygous deletions but no sequence mutations in coding regions of p15 or p16 in human primary bladder tumors. Mol Carcinog 14:147-151, 1995.
34. Cairns P, Mao L, Merlo A, et al. Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science 265:415-416, 1994.
35. Dietrich WF, Lander ES, Smith JS, et al. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 75:631-639, 1993.
36. Potter M, Mushinski EB, Wax JS, Hartley J, Mock BA. Identification of two genes on chromosome 4 that determine resistance to plasmacytoma induction in mice. Cancer Res 54:969-975, 1994.
37. Lee G-H, Bennett LM, Carabeo RA, Drinkwater NR. Identification of hepatocarcinogen-resistance genes in DBA/2 mice. Genetics 139:387-395, 1995.
38. Abbott CM, Blank R, Eppig JT, et al. Mouse chromosome 4. Mamm Genome 4:S58-S71, 1993.
39. Simon D, Knowles BB, Weith A. Abnormalities of chromosome 1 and loss of heterozygosity on 1p in primary hepatomas. Oncogene 6:735-740, 1991.
40. Moley JF, Brother MB, Fong CT, et al. Consistent association of 1p loss of heterozygosity with pheochromocytoma from patients with multiple endocrine neoplasia type 2 syndromes. Cancer Res 52:770-774, 1992.
41. Leister I, Weith A, Bruderlein S, et al. Human colorectal cancer: High frequency of deletions at chromosome 1p35. Cancer Res 50:7232-7235, 1990.
42. Genuardi M, Tsihira H, Anderson DE, Anderson DE, Saundes GF. Distal deletion of chromosome 1p in ductal carcinoma of the breast. Am J Hum Genet 45:73-82, 1989.
43. Fong CT, Dracopoli NC, White PS, et al. Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: Correlation with N-myc amplification. Proc Natl Acad Sci USA 86:3753-3757, 1989.
44. Dracopoli NC, Harnett P, Bale SJ, et al. Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression. Proc Natl Acad Sci USA 86:4614-4618, 1989.
45. Devilee P, van Vliet M, Bardoel A, et al. Frequent somatic imbalance of marker alleles for chromosome 1 in human primary breast carcinoma. Cancer Res 51:1020-1025, 1991.
46. Bale SJ, Dracopoli NC, Tucker MA, et al. Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p. N Engl J Med 320:1367-1372, 1989.
47. INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 371:257-261, 1994.
48. Hirai H, Roussel MF, Kato J, Ashmun RA, Sherr CJ. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol Cell Biol 15:2672-2681, 1995.